Global Drug Discovery Services Market Size and Trends Report Segmented by Service Type (Biology Services, Chemistry Services), Therapy Area (Cancer, Neurology, Infectious Diseases), Regional Forecast to 2030
The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by the increasing demand for outsourced drug discovery activities, advancements in screening technologies, and rising prevalence of chronic diseases. Drug discovery services play a critical role in accelerating the drug development process by enabling pharmaceutical and biotech companies to leverage specialized expertise and technologies. To learn more about the research report, download a sample report.
Report Overview
Drug discovery services involve a range of activities, including target identification, lead optimization, and preclinical evaluation, aimed at identifying novel therapeutic candidates. The market is centered on providers offering comprehensive solutions to streamline research timelines, reduce costs, and enhance the success rate of drug development. Increasing investment in pharmaceutical R&D and the growing trend of outsourcing by small and mid-sized enterprises (SMEs) are major contributors to market growth.
To learn more about this report, download the PDF brochure
Integration of Advanced Technologies in Drug Discovery Services
Recent developments in the drug discovery services market are driven by the integration of advanced technologies aimed at improving efficiency and reducing the time required to bring new drugs to market. Key innovations include the adoption of artificial intelligence (AI) for predictive modeling, high-throughput screening technologies, and next-generation sequencing platforms. Providers such as Charles River Laboratories and WuXi AppTec have introduced advanced AI-driven solutions to identify promising drug candidates with higher accuracy and speed. Additionally, cloud-based platforms are being leveraged to facilitate seamless collaboration between research organizations, enhancing data sharing and project management.
Key Challenges in Drug Discovery Services: Cost, Regulatory Hurdles, and Intellectual Property Concerns
The drug discovery services market faces challenges, including high service costs, stringent regulatory requirements, and concerns over intellectual property (IP) rights. The complexity of managing IP ownership during collaborations between service providers and clients can create legal and operational hurdles. Moreover, compliance with evolving regulations across different regions increases the burden on service providers, requiring continuous investment in quality management and certification processes. Overcoming these challenges is crucial to fostering innovation and ensuring the continued growth of the drug discovery services market.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
Leading companies in the drug discovery services market, such as Charles River Laboratories, WuXi AppTec, Eurofins Scientific, Evotec, and Syngene International, are advancing their service offerings by adopting AI-enabled platforms, expanding their global footprint, and forming strategic partnerships with pharmaceutical and biotech companies. These players are also investing in cutting-edge technologies to support their clients’ research needs, ensuring scalability, adaptability, and regulatory compliance.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 15% |
| Market Drivers |
|
| Market Opportunities |
|
| Segment Scope | Process, Service, Drug Type, Therapy Area |
| Regional Scope |
|
| Key Companies Mapped | Charles River Laboratories, WuXi AppTec, Eurofins Scientific, Evotec (part of Perkin Elmer), Syngene International, Thermo Fisher Scientific, Genscript Biotech, Pharmaron, Sygnature Discovery, and Jubilant Biosys |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Drug Discovery Services Market Segmentation
This report by Medi-Tech Insights provides the size of the global drug discovery services market at the regional- and country-level from 2023 to 2030. The report further segments the market based on process, service, drug type and therapy area.
- Market Size & Forecast (2023-2030), By Process, USD Billion
- Target/Hit Identification
- Lead Generation (Hit to Lead)
- Lead Optimization
- Candidate Identification/Selection
- Market Size & Forecast (2023-2030), By Service, USD Billion
- Biology Services
- Chemistry Services
- Market Size & Forecast (2023-2030), By Drug Type, USD Billion
- Biologics
- Small molecules
- Market Size & Forecast (2023-2030), By Therapy Area, USD Billion
- Infectious Diseases
- Cancer
- Cardiovascular
- CNS
- Respiratory
- Immunology
- Gastrointestinal
- Others
- Market Size & Forecast (2023-2030), By Region, USD Billion
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the drug discovery services market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the drug discovery services market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region holds the highest market share?
- Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players in the market?
- What are the key strategies adopted by market players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Global Drug Discovery Services Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising trend for outsourcing drug discovery activities
- Integration of AI and ML in drug discovery services
- Advancements in screening technologies
- Growing prevalence of chronic and infectious diseases
- Restraints/Challenges
- High cost of drug discovery services
- Regulatory compliance challenges across regions
- Concerns over intellectual property rights
- Opportunities
- Emerging markets offer high growth opportunities
- Drug discovery services in the field of personalized medicine
- Drug discovery services for rare diseases
- Key Market Trends
- Industry Speaks
- Drivers
- Market Dynamics
- Drug Discovery Services Market Size & Forecast (2023-2030), By Process, USD Billion
- Introduction
- Target/Hit Identification
- Lead Generation (Hit to Lead)
- Lead Optimization
- Candidate Identification/Selection
- Drug Discovery Services Market Size & Forecast (2023-2030), By Service, USD Billion
- Introduction
- Biology Services
- Chemistry Services
- Drug Discovery Services Market Size & Forecast (2023-2030), By Drug Type, USD Billion
- Introduction
- Biologics
- Small Molecules
- Drug Discovery Services Market Size & Forecast (2023-2030), By Therapy Area, USD Billion
- Introduction
- Infectious Diseases
- Cancer
- Cardiovascular
- CNS
- Respiratory
- Immunology
- Gastrointestinal
- Others
- Global Drug Discovery Services Market Size & Forecast (2023-2030), By Region, USD Billion
- Introduction
- North America Drug Discovery Services Market Size & Forecast (2023-2030), By Country, USD Billion
- US
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Canada
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- US
- Europe Drug Discovery Services Market Size & Forecast (2023-2030), By Country, USD Billion
- UK
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Germany
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- France
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Italy
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Spain
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Rest of Europe
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- UK
- Asia Pacific (APAC) Drug Discovery Services Market Size & Forecast (2023-2030), By Country, USD Billion
- China
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Japan
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- India
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Rest of Asia Pacific
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- China
- Latin America (LATAM) Drug Discovery Services Market Size & Forecast (2023-2030), USD Billion
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Middle East & Africa (MEA) Drug Discovery Services Market Size & Forecast (2023-2030), USD Billion
- Market Size & Forecast, By Process (USD Billion)
- Market Size & Forecast, By Service (USD Billion)
- Market Size & Forecast, By Drug Type (USD Billion)
- Market Size & Forecast, By Therapy Area (USD Billion)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Charles River Laboratories
- WuXi AppTec
- Eurofins Scientific
- Evotec (part of PerkinElmer)
- Syngene International
- Thermo Fisher Scientific
- GenScript Biotech
- Pharmaron
- Jubilant Biosys
- Sygnature Discovery
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Pharmaceutical Companies, Biotech Companies, Academic Institutes
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
